Renaud Capdeville
Impact in
- Hematology top 0.05%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Gastroenterology top 0.05%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Hematology 31
- Chronic Myeloid Leukemia Treatments 25
- Acute Myeloid Leukemia Research 4
-
- Pharmacogenetics and Drug Metabolism 7
- Co-authors
- Charles L. Sawyers (6 shared papers)Moshe Talpaz (6 shared papers)Debra J. Resta (6 shared papers)J. Ford (6 shared papers)Elisabeth Buchdunger (4 shared papers)Hagop M. Kantarjian (4 shared papers)Bin Peng (8 shared papers)Sayuri Ohno-Jones (2 shared papers)
- Journals
- New England Journal of Medicine (6 papers)Blood (5 papers)European Journal of Cancer (5 papers)Clinical Cancer Research (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Renaud Capdeville
57 papers receiving 20.4k citations
Renaud Capdeville's Hit Papers
Peers
Comparison fields: 5 of 143
- Hematology 7.3k
- Gastroenterology 3.4k
- Genetics 1k
- Pharmacology 897
- Oncology 1.8k
Countries citing papers authored by Renaud Capdeville
This map shows the geographic impact of Renaud Capdeville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renaud Capdeville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renaud Capdeville more than expected).
Fields of papers citing papers by Renaud Capdeville
This network shows the impact of papers produced by Renaud Capdeville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renaud Capdeville. The network helps show where Renaud Capdeville may publish in the future.
Co-authors
The 25 scholars most cited alongside Renaud Capdeville, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia Hit paper breakdown → | 2001 | 4249 |
| 2 | Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors Hit paper breakdown → | 2002 | 3629 |
| 3 | Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Hit paper breakdown → | 2003 | 2900 |
| 4 | Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome Hit paper breakdown → | 2001 | 2276 |
| 5 | Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia Hit paper breakdown → | 2002 | 1693 |
| 6 | Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal Tumor Hit paper breakdown → | 2001 | 1656 |
| 7 | Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug Hit paper breakdown → | 2002 | 1189 |
| 8 | Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Hit paper breakdown → | 1998 | 768 |
| 9 | 2004 | 401 | |
| 10 | 2006 | 353 | |
| 11 | 2004 | 200 | |
| 12 | 2004 | 141 | |
| 13 | 2004 | 134 | |
| 14 | 2003 | 133 | |
| 15 | 2004 | 133 | |
| 16 | 2018 | 130 | |
| 17 | 2002 | 112 | |
| 18 | 2005 | 110 | |
| 19 | Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results. | 2002 | 106 |
| 20 | Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate. | 2002 | 95 |
About Renaud Capdeville
Renaud Capdeville is a scholar working on Hematology, Pharmacology, Pediatrics, Perinatology and Child Health, Gastroenterology and Oncology, having authored 58 papers that have together received 21.6k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (25 papers), Pharmaceutical studies and practices (7 papers), Pharmacogenetics and Drug Metabolism (7 papers), Acute Myeloid Leukemia Research (4 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Polyamine Metabolism and Applications (3 papers), Neutropenia and Cancer Infections (3 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Hematology (7.3k citations), Gastroenterology (3.4k citations), Genetics (1k citations), Pharmacology (897 citations) and Oncology (1.8k citations). Renaud Capdeville has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Charles L. Sawyers, Moshe Talpaz, Debra J. Resta, J. Ford, Elisabeth Buchdunger, Hagop M. Kantarjian, Bin Peng, Sayuri Ohno-Jones, Nicholas Lydon and Alex Matter. Their work appears in journals such as New England Journal of Medicine, Blood, European Journal of Cancer, Clinical Cancer Research and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.